alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE>                     5
<LEGEND>
               This schedule  contains  restated summary  financial  information
               extracted  from the unaudited  condensed  consolidated  financial
               statements  included  in the  registrant's  Form  10-Q/A  for the
               period ended September 30, 1997 and is qualified  in its entirety
               by reference to such Form 10-Q/A.
</LEGEND>
<CIK>                         0001016439
<NAME>                        Intelligroup, Inc.
<MULTIPLIER>                                   1,000
<CURRENCY>                                     U.S. Dollars
       
<S>                             <C>
<PERIOD-TYPE>                   9-mos
<FISCAL-YEAR-END>                              Dec-31-1997
<PERIOD-START>                                 Jan-01-1997
<PERIOD-END>                                   Sep-30-1997
<EXCHANGE-RATE>                                1
<CASH>                                         0
<SECURITIES>                                   0
<RECEIVABLES>                                  0
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               0
<PP&E>                                         0
<DEPRECIATION>                                 0
<TOTAL-ASSETS>                                 0
<CURRENT-LIABILITIES>                          0
<BONDS>                                        0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       0
<OTHER-SE>                                     0
<TOTAL-LIABILITY-AND-EQUITY>                   0
<SALES>                                        61,663
<TOTAL-REVENUES>                               61,663
<CGS>                                          42,857
<TOTAL-COSTS>                                  42,857
<OTHER-EXPENSES>                               13,034
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             (211)
<INCOME-PRETAX>                                5,983
<INCOME-TAX>                                   2,230
<INCOME-CONTINUING>                            3,753
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   3,753
<EPS-PRIMARY>                                  0.33 <F1>
<EPS-DILUTED>                                  0.31 <F2>
<FN>
<F1>      This amount represents Basic Earnings per Share in accordance with the
          requirements of Statement of Financial  Accounting Standards No. 128 -
          "Earnings per Share".

<F2>      This amount  represents  Diluted Earnings per Share in accordance with
          the  requirements of Statement of Financial  Accounting  Standards No.
          128 - "Earnings per Share".
</FN>
        

</TABLE>
**Exhibit 10.3C**

**AMENDMENT NUMBERTHREE****TO THE****ALABAMA NATIONAL BANCORPORATION****PLAN FOR THE DEFERRAL OF COMPENSATION****BY NON-EMPLOYEE DIRECTORS OF THE SUBSIDIARYBANKS**

**WHEREAS,**Alabama National BanCorporation (“ANB”) maintains the Alabama National BanCorporation Plan for theDeferral of Compensation by Non-Employee Directors of the Subsidiary Banks (the “Plan”); and

**WHEREAS,**pursuant to Section7(d) of the Plan, ANB reserved the right to amend the Plan; and

**WHEREAS,**currently, the non-employee directors of four ofANB’s subsidiary banks (National Bank of Commerce of Birmingham, First American Bank, Community Bank of Naples and Peoples State Bank of Groveland) are eligible to participate in the Plan; and

**WHEREAS,** the Board of Directors of ANB has approved an amendment to the Plan such that non-employee directors of a fifth subsidiary bank, Citizens & Peoples Bank, N.A.,shall also be eligible to participate in the Plan. 

**NOW, THEREFORE,** the Plan is hereby amended effective as of March 1, 2002 asfollows:

1.        Amend Exhibit A to the Plan by adding the following to the list of eligible subsidiary banks:

Citizens & Peoples Bank, N.A.

2.        All of the other terms, provisions and conditions of the Plan not herein amended shallremain in full force and effect.

**IN WITNESS WHEREOF,** ANB has caused this amendment to be executed by duly authorizedrepresentatives this 27th day of February, 2002.

 

| **ATTEST:**                               |                    | **ALABAMA NATIONAL BANCORPORATION** |
|-------------------------------------------|-------------------------|-------------------------------------|
|  /s/   KIMBERLY MOORE |                    | By:                            | /s/   RICHARD MURRAY,IV |
|                                           |                    |                                |  |
| Its:                                      | **Corporate Secretary** |                                | Its: | **President** |
|                                           |                         |                                     |  |  |

[SEAL]
<PAGE>   1

                                                                    EXHIBIT 21.1

                                  SUBSIDIARIES


                 Innkeepers USA Trust, a Maryland real estate investment trust
 the "Company"), operates principally through two entities, (i) Innkeepers
 financial Corporation, a Virginia corporation ("IFC"), which is a wholly-owned
 subsidiary of the Company, and (ii) Innkeepers USA Limited Partnership, a
 Virginia limited partnership (the "Partnership"), of which IFC owns an
 approximately 81.9% interest.  All of the Company's hotels are owned by the
 partnership or subsidiary limited partnerships which are owned 99% by the
 partnership and 1% by either the Company directly or corporations which are
 holly-owned by the Company.
<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> 9
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          MAR-31-1997
<PERIOD-START>                             APR-01-1996
<PERIOD-END>                               MAR-31-1997
<CASH>                                         718,157
<INT-BEARING-DEPOSITS>                       6,525,626
<FED-FUNDS-SOLD>                                     0
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                          0
<INVESTMENTS-CARRYING>                       3,594,607
<INVESTMENTS-MARKET>                         3,547,000
<LOANS>                                     15,552,545
<ALLOWANCE>                                     40,171
<TOTAL-ASSETS>                              26,998,783
<DEPOSITS>                                  22,816,474
<SHORT-TERM>                                         0
<LIABILITIES-OTHER>                            176,834
<LONG-TERM>                                          0
<COMMON>                                         2,319
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                   3,961,242
<TOTAL-LIABILITIES-AND-EQUITY>              26,998,783
<INTEREST-LOAN>                              1,084,447
<INTEREST-INVEST>                              235,657
<INTEREST-OTHER>                               373,258
<INTEREST-TOTAL>                             1,693,362
<INTEREST-DEPOSIT>                             939,598
<INTEREST-EXPENSE>                             939,598
<INTEREST-INCOME-NET>                          753,764
<LOAN-LOSSES>                                   10,302
<SECURITIES-GAINS>                               3,178
<EXPENSE-OTHER>                                672,958
<INCOME-PRETAX>                                 99,269
<INCOME-PRE-EXTRAORDINARY>                      73,949
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    73,949
<EPS-PRIMARY>                                      .34
<EPS-DILUTED>                                      .34
<YIELD-ACTUAL>                                    3.05
<LOANS-NON>                                          0
<LOANS-PAST>                                         0
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                29,869
<CHARGE-OFFS>                                        0
<RECOVERIES>                                         0
<ALLOWANCE-CLOSE>                               40,171
<ALLOWANCE-DOMESTIC>                            40,171
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0
        


</TABLE>
Exhibit 32.1





CERTIFICATION OF PERIODIC REPORT


As adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002





In connection with the Quarterly Report on Form 10-Q for the third quarter ended March 31, 2011 of Integrated BioPharma, Inc. (the “Company”) as filed with the Securities and Exchange Commission on the date hereof (the “Report”), E. Gerald Kay, the President and Chief Executive Officer of Integrated BioPharma, Inc.certifies, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to his knowledge:





(1)
the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and





(2)
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.





This certification accompanies the Report pursuant to Section 906 of Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.





A signed original of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.




Date:  May 17, 2011
By:
/s/ E. Gerald KayE. Gerald Kay,President and Chief Executive Officer
Exhibit 32.2


                        CERTIFICATION OF PERIODIC REPORT
           As adopted to Section 906 of the Sarbanes-Oxley Act of 2002


I, Gregory A. Gould, the Senior Vice President and Chief Financial  Officer of
Integrated  BioPharma,  Inc. (the  "Company"),  certify, pursuant to Section 906
of the Sarbanes-Oxley Act of 2003, 18 U.S.C. Section 1350, that:

(1)      the Quarterly Report on Form 10-QSB of the Company for the quarterly
         period ended March 31, 2005 (the "Report") fully complies with the
         requirements of Section 13(a) or 15(d) of the Securities Exchange Act
         of 1934 (15 U.S.C. 78m or 78o(d)); and

(2)      the information  contained in the Report fairly presents, in all
         material  respects,  the financial  condition and results of
         operations of the Company.


Date:   May 16,  2005          By: /s/ Gregory A. Gould
                               ------------------------
                               Gregory A. Gould
                               Senior Vice President and Chief Financial Officer
**Exhibit** **32.1**

 

**ANTARES PHARMA, INC.**

**CERTIFICATION OF CHIEF EXECUTIVE OFFICER**

**PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C. 1350)**

 

The undersigned, Jack E. Stover, the Chief Executive Officer of Antares Pharma, Inc. (the “Company”), has executed this Certification in connection with the filing with the Securities and Exchange Commission of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2008 (the “Report”).

 

The undersigned hereby certifies that:

 

|   | 1. | The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and |
|--------|----|-------------------------------------------------------------------------------------------------------------------|

 

|   | 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|--------|----|------------------------------------------------------------------------------------------------------------------------------------------------------|

 

IN WITNESS WHEREOF, the undersigned has executed this Certification as of the 14th day of August, 2008.

 

|   |   |   |   | /s/ Jack E. Stover                                        |
|--------|--------|--------|--------|-----------------------------------------------------------|
|   |   |   |   | Jack E. Stover

Vice Chairman and Chief Executive Officer |
|   |   |   |   |                                                      |
Exhibit 21.0

Vermillion, Inc. Subsidiaries

December 31, 2008



|                                         |  |                                         
|---------------------------------------- |  | ----------------------------------------
|Subsidiary                               |  | State/Country of
Incorporation/Formation
|IllumeSys Pacific, Inc.                  |  | California                              
|Ciphergen Technologies, Inc.             |  | California                              
|Ciphergen Biosystems Ltd.                |  | United Kingdom                          
|Ciphergen Biosystems A/S                 |  | Denmark                                 
|Ciphergen Biosystems AG                  |  | Switzerland                             
|Ciphergen Biosystems KK                  |  | Japan                                   
|Ciphergen Biosystems International, Inc. |  | Delaware                                
|Ciphergen (Beijing) Biosystems Co., Ltd. |  | China                                   

Ciphergen
Biosystems International, Inc. Subsidiaries

December 31, 2008



|                            |  |                                         
|--------------------------- |  | ----------------------------------------
|Subsidiary                  |  | State/Country of
Incorporation/Formation
|Ciphergen Biosystems GmbH   |  | Germany                                 
|Ciphergen Biosystems S.r.l. |  | Italy                                   
|Ciphergen Biosystems EURL   |  | France
---



Exhibit 14

Donald E. Hulse, P.E.

GUSTAVSON ASSOCIATES, LLC

5757 Central Avenue, Suite D, Boulder, Colorado 80301

Telephone: 303-443-2209

Facsimile: 303-443-3156



CONSENT OF EXPERT

March 10, 2009

British Columbia Securities Commission

Alberta Securities Commission

Saskatchewan Financial Services Commission

Manitoba Securities Commission

Ontario Securities Commission

New Brunswick Securities Commission

Nova Scotia Securities Commission

Registrar of Securities, Prince Edward Island

Securities Commission of Newfoundland and Labrador

Registrar of Securities, Northwest Territories

Registrar of Securities, Nunavut

Registrar of Securities, Yukon

United States Securities and Exchange Commission



Re:

Annual Information Form dated March 10, 2009 (the Annual Information Form) of Minefinders Corporation Inc. (the Company).



I refer to the report entitled "NI 43-101 Technical Report on the Minable Reserve for the Dolores Gold-Silver Project, Chihuahua State, Mexico" dated March 25, 2008 (the "Report") as referenced in the Annual Information Form and documents incorporated by reference therein.



This letter is being filed as my consent to the use of my name and the Report in the Annual Information Form and in documents incorporated by reference therein.



I confirm that I have read the Annual Information Form and I have no reason to believe that there are any misrepresentations that are derived from the Report referred to above or that are within my knowledge as a result of the services I performed in connection with such Report.



I consent to the filing of this consent with the United States Securities and Exchange Commission as part of the Company's Form 40-F dated March 10, 2009, and any amendment thereto,  including post-effective amendments and as part of a post-effective amendment to the Company's Form F-10, to incorporate the Company's Form 40-F dated March 10, 2009.

Yours truly,



/s/ Donald E. Hulse

Donald E. Hulse





---
**Exhibit
        32.2**
 
 **CERTIFICATION
        PURSUANT TO**
 **18
        U.S.C. SECTION 1350**
 **AS
        ADOPTED PURSUANT TO**
 **SECTION
        906 OF THE SARBANES-OXLEY ACT OF 2002**
 
 In
        connection with the Quarterly Report of Altair Nanotechnologies Inc. (the
        “Company”) on Form 10-Q for the quarterly period ended June 30, 2006 as filed
        with the Securities and Exchange Commission on the date hereof (the “Report”),
        I, Edward H. Dickinson, Chief Financial Officer of the Company, certify,
        pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley
        Act of 2002, that to the best of my knowledge:
 
 (1)  The
        Report fully complies with the requirements of section 13(a) or 15(d) of
        the
        Securities Exchange Act of 1934; and
 
 (2)  The
        information contained in the Report fairly presents, in all material respects,
        the financial condition and results of operations of the Company.
 
 
 /s/
                  Edward H. DickinsonEdward
                  H. Dickinson, Chief Financial OfficerAugust
                  7, 2006
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-END>                               DEC-31-1998
<CASH>                                           5,649
<SECURITIES>                                         0
<RECEIVABLES>                                      209
<ALLOWANCES>                                        30
<INVENTORY>                                          0
<CURRENT-ASSETS>                                 5,828
<PP&E>                                         240,321
<DEPRECIATION>                                 113,228
<TOTAL-ASSETS>                                 134,904
<CURRENT-LIABILITIES>                            2,556
<BONDS>                                        149,265
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                   134,904
<SALES>                                              0
<TOTAL-REVENUES>                                28,726
<CGS>                                                0
<TOTAL-COSTS>                                    9,886
<OTHER-EXPENSES>                                20,035
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              18,035
<INCOME-PRETAX>                               (19,230)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (19,230)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                 51,183
<CHANGES>                                            0
<NET-INCOME>                                    31,953
<EPS-PRIMARY>                                   322.55
<EPS-DILUTED>                                   322.55
        

</TABLE>
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
UNAUDITED CONSOLIDATED BALANCE SHEET AS OF MARCH 31, 1997 AND THE UNAUDITED
STATEMENT OF OPERATIONS FOR THE THREE MONTHS ENDED MARCH 31, 1997 IN THE REPORT
ON FORM 10-QSB FOR THE THREE MONTHS ENDED MARCH 31, 1997 OF BRISTOL TECHNOLOGY
SYSTEMS, INC. AND IS QUALIFIED IN IS ENTIRETY BY REFERENCE TO SUCH FINANCIAL 
STATEMENT.
</LEGEND>
<MULTIPLIER> 1
<CURRENCY> U.S. DOLLARS
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               MAR-31-1997
<EXCHANGE-RATE>                                      1
<CASH>                                       4,519,770
<SECURITIES>                                         0
<RECEIVABLES>                                1,305,638
<ALLOWANCES>                                    48,252
<INVENTORY>                                  2,204,577
<CURRENT-ASSETS>                             8,116,085
<PP&E>                                         315,541
<DEPRECIATION>                                  50,853
<TOTAL-ASSETS>                              10,236,629
<CURRENT-LIABILITIES>                        2,419,367
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         4,746
<OTHER-SE>                                   7,743,282
<TOTAL-LIABILITY-AND-EQUITY>                10,236,629
<SALES>                                      2,660,298
<TOTAL-REVENUES>                             2,724,550
<CGS>                                        1,860,931
<TOTAL-COSTS>                                3,145,752
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              12,734
<INCOME-PRETAX>                               (433,936)
<INCOME-TAX>                                     1,050
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (434,986)
<EPS-PRIMARY>                                    (0.09)
<EPS-DILUTED>                                    (0.09)
        



</TABLE>
# **Exhibit 32**

# ***CERTIFICATION PURSUANT TO SECTION 906OF THE SARBANES-OXLEY ACT OF 2002***

Pursuant to 18U.S.C. 1350, we the undersigned Chief Executive Officer and Chief FinancialOfficer, respectively, of Canterbury Park Holding Corporation (the “Company”),hereby certify that:

(1)                                                          TheAnnual Report of the Company on Form 10-K for the period ended December 31,2006, (the “Report”) fully complies with the requirements of Section 13(a) or15(d) of the Securities Exchange Act of 1934; and

(2)                                                          Theinformation contained in the Report fairly presents, in all material respects,the financial condition and results of operations of the Company.
|                 |                                        |
|----------------------|---------------------------------------------|
|                      |                                        |
| Date: March 30, 2007 | /s/ Randall D. Sampson                      |   |
|                 | Randall D. Sampson,                         |
|                 | President, and Chief Executive Officer      |
|                 | Canterbury Park Holding Corporation         |
|                 |                                        |
| Date: March 30, 2007 | /s/ David C. Hansen                         |   |
|                 | David C. Hansen,                            |
|                 | Vice President, and Chief Financial Officer |
|                 | Canterbury Park Holding Corporation         |
|                      |                                             |  |  |

 

----